STAT

STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise

STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promiseWorldPing

Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent injections compared to a standard treatment.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

35-year monitoring study clarifies ecological forces behind Lyme disease riskWorldPing
Phys.org

35-year monitoring study clarifies ecological forces behind Lyme disease risk

Tick-borne diseases are on the rise in the United States. Lyme disease is the most commonly reported, with nearly half a million people diagnosed each year. Caused by the bacterium Borrelia burgdorferi, it is most often spread by bites from blacklegged ticks.

Brief by WorldPing · Original reporting by Phys.org

Is an iPhone 15 still worth your money in 2026?WorldPing
Engadget

Is an iPhone 15 still worth your money in 2026?

Buying an older iPhone is a great way to save money while taking advantage of Apple's long support. But is the iPhone 15 too old to be worth it now?

Brief by WorldPing · Original reporting by Engadget